rs56229512

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001035.3(RYR2):​c.4198A>G​(p.Ser1400Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0215 in 1,613,390 control chromosomes in the GnomAD database, including 390 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 19 hom., cov: 31)
Exomes 𝑓: 0.022 ( 371 hom. )

Consequence

RYR2
NM_001035.3 missense

Scores

6
11

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:21

Conservation

PhyloP100: 3.54
Variant links:
Genes affected
RYR2 (HGNC:10484): (ryanodine receptor 2) This gene encodes a ryanodine receptor found in cardiac muscle sarcoplasmic reticulum. The encoded protein is one of the components of a calcium channel, composed of a tetramer of the ryanodine receptor proteins and a tetramer of FK506 binding protein 1B proteins, that supplies calcium to cardiac muscle. Mutations in this gene are associated with stress-induced polymorphic ventricular tachycardia and arrhythmogenic right ventricular dysplasia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), RYR2. . Gene score misZ 5.7809 (greater than the threshold 3.09). Trascript score misZ 6.4158 (greater than threshold 3.09). GenCC has associacion of gene with hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, catecholaminergic polymorphic ventricular tachycardia 1, arrhythmogenic right ventricular dysplasia 2, catecholaminergic polymorphic ventricular tachycardia.
BP4
Computational evidence support a benign effect (MetaRNN=0.008523673).
BP6
Variant 1-237591776-A-G is Benign according to our data. Variant chr1-237591776-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 43782.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-237591776-A-G is described in Lovd as [Benign]. Variant chr1-237591776-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0152 (2310/152266) while in subpopulation NFE AF= 0.0239 (1627/68018). AF 95% confidence interval is 0.023. There are 19 homozygotes in gnomad4. There are 1093 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2310 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RYR2NM_001035.3 linkuse as main transcriptc.4198A>G p.Ser1400Gly missense_variant 32/105 ENST00000366574.7 NP_001026.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RYR2ENST00000366574.7 linkuse as main transcriptc.4198A>G p.Ser1400Gly missense_variant 32/1051 NM_001035.3 ENSP00000355533 P1Q92736-1
RYR2ENST00000660292.2 linkuse as main transcriptc.4198A>G p.Ser1400Gly missense_variant 32/106 ENSP00000499787
RYR2ENST00000659194.3 linkuse as main transcriptc.4198A>G p.Ser1400Gly missense_variant 32/105 ENSP00000499653
RYR2ENST00000609119.2 linkuse as main transcriptc.4198A>G p.Ser1400Gly missense_variant, NMD_transcript_variant 32/1045 ENSP00000499659

Frequencies

GnomAD3 genomes
AF:
0.0152
AC:
2310
AN:
152148
Hom.:
19
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00391
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.0181
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0126
Gnomad FIN
AF:
0.0170
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0239
Gnomad OTH
AF:
0.0124
GnomAD3 exomes
AF:
0.0167
AC:
4155
AN:
248504
Hom.:
37
AF XY:
0.0173
AC XY:
2331
AN XY:
134816
show subpopulations
Gnomad AFR exome
AF:
0.00363
Gnomad AMR exome
AF:
0.00830
Gnomad ASJ exome
AF:
0.0218
Gnomad EAS exome
AF:
0.000224
Gnomad SAS exome
AF:
0.0135
Gnomad FIN exome
AF:
0.0199
Gnomad NFE exome
AF:
0.0234
Gnomad OTH exome
AF:
0.0195
GnomAD4 exome
AF:
0.0222
AC:
32424
AN:
1461124
Hom.:
371
Cov.:
30
AF XY:
0.0221
AC XY:
16053
AN XY:
726786
show subpopulations
Gnomad4 AFR exome
AF:
0.00290
Gnomad4 AMR exome
AF:
0.00848
Gnomad4 ASJ exome
AF:
0.0193
Gnomad4 EAS exome
AF:
0.0000757
Gnomad4 SAS exome
AF:
0.0131
Gnomad4 FIN exome
AF:
0.0221
Gnomad4 NFE exome
AF:
0.0252
Gnomad4 OTH exome
AF:
0.0189
GnomAD4 genome
AF:
0.0152
AC:
2310
AN:
152266
Hom.:
19
Cov.:
31
AF XY:
0.0147
AC XY:
1093
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.00390
Gnomad4 AMR
AF:
0.0109
Gnomad4 ASJ
AF:
0.0181
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.0126
Gnomad4 FIN
AF:
0.0170
Gnomad4 NFE
AF:
0.0239
Gnomad4 OTH
AF:
0.0123
Alfa
AF:
0.0217
Hom.:
59
Bravo
AF:
0.0139
TwinsUK
AF:
0.0259
AC:
96
ALSPAC
AF:
0.0262
AC:
101
ESP6500AA
AF:
0.00369
AC:
14
ESP6500EA
AF:
0.0218
AC:
180
ExAC
AF:
0.0173
AC:
2089
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0222
EpiControl
AF:
0.0222

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:21
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 13, 2012Ser1400Gly in exon 32 of RYR2: This variant is classified as benign based on its high frequency in the general population (dbSNP rs56229512; NHLBI Exome Sequenc ing Project, http://evs.gs.washington.edu/EVS). G=157/A=6507 (EA chromosomes, E SP project) -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, no assertion criteria providedclinical testingStanford Center for Inherited Cardiovascular Disease, Stanford UniversityFeb 10, 2015Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Ser1400Gly in the RYR2 gene. This variant is present in the 1000 Genomes browser with an overall allele frequency of 0.96% (http://browser.1000genomes.org/index.htm). This means that it is present in some 2% of individuals. In some ethnic subgroups the allele frequency is as high as 2-3%. This amino acid location is not conserved across paralog proteins RYR1-RYR3, suggesting that it is not important for channel function (https://cardiodb.org/Paralogue_Annotation/residue.php?gene=RYR2&position=1400). Yano et al. (2006) have reported that disease-causing variants in RYR2 cluster within 3 hotspot regions: the N-terminal domain (residues 77-433), the central domain (residues 2246-2534), and the C-terminal domain (residues 3778-4959). This variant falls outside of those 3 hotspots. No variation at nearby residues has been reported in HGMD in association with CPVT or ARVC (HGMD professional version as of January 17, 2014). ClinVar lists it as “Benign”, as submitted by Harvard’s Laboratory for Molecular Medicine. As of 2/2/2015 it has been reported in 14/1897 (0.74%) of African American individuals and 178/4126 (4.31%) of Caucasian individuals in the NHLBI Exome Sequencing Project dataset (for overall prevalence of 3.19%; http://evs.gs.washington.edu/EVS/), and two of the Caucasians with the variant were homozygous for it. The phenotype of the ESP individuals is not publicly available, however the cohorts that were merged to create this dataset were all either general population samples or samples recruited for common cardiovascular disease such as hypertension. It is listed in dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP) as rs56229512. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
not provided Benign:6
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015This variant is associated with the following publications: (PMID: 25925909, 33232181) -
Benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute-- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024RYR2: BS1, BS2 -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 14, 2023- -
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Catecholaminergic polymorphic ventricular tachycardia Benign:1
Benign, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthFeb 05, 2024- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthMar 15, 2018- -
Catecholaminergic polymorphic ventricular tachycardia 1;C1832931:Arrhythmogenic right ventricular dysplasia 2;C5542154:Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 28, 2021- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 19, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Arrhythmogenic right ventricular dysplasia 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.54
D;T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.27
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.77
T;T
MetaRNN
Benign
0.0085
T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Benign
1.9
L;.
MutationTaster
Benign
0.99
N
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.6
N;.
REVEL
Uncertain
0.31
Sift
Benign
0.12
T;.
Polyphen
0.0040
B;.
Vest4
0.13
MPC
0.34
ClinPred
0.011
T
GERP RS
3.2
Varity_R
0.090
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56229512; hg19: chr1-237755076; API